Attached files

file filename
EX-31.2 - CERTIFICATION - TIANYIN PHARMACEUTICAL CO., INC.ex31two.htm
EX-31.1 - CERTIFICATION - TIANYIN PHARMACEUTICAL CO., INC.ex31one.htm
EX-32.1 - CERTIFICATION - TIANYIN PHARMACEUTICAL CO., INC.ex32one.htm
10-K - TIANYIN PHARMACEUTICAL CO., INC. - TIANYIN PHARMACEUTICAL CO., INC.tpi10k63010.htm
 
 


 

 
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Tianyin Pharmaceutical Co., Inc. (the “Company”) on Form 10-K for the year ending June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report’), I, James Jiayan Tong, Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.


Date:  September 29, 2010
 
/s/  James Jiayuan Tong
James Jiayuan Tong
Chief Accounting Officer